AdvaMed 2014 Feature: Diagnostic Photonics

The 2014 AdvaMed conference is only 3 weeks away! Chicago is hosting the conference this year and in an effort to highlight the local medtech community, I am doing weekly features on local medtech companies. The Medtech community here in Chicago has been steadily growing. Over the past couple years we have seen a large…


FDA moves toward standardized medical device labeling

Tucked away in the Federal Register are the FDA’s intentions to test its own labeling format to “inform FDA’s planned regulatory approach to standardizing medical device labeling across the United States.” The test will consist of 38 respondents (including 8 at participating hospitals and 30 at FDA headquarters) that will compare the possible standardized labeling format of…

Absorb 640 X 480

Abbott Begins Trials on Bioresorbable Vascular Scaffold

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the world’s first drug eluting BVS and functions like a metallic stent by opening up…


Abbott invests $60M in optics

Abbott Laboratories ($ABT) will invest $60 million in an intraocular lens manufacturing plant in Malaysia. The plant is expected to employ about 500 people and be operational next year, producing 1 million sets of IOLs a year.

Copyright © 2014 WhiteCityNews, All rights reserved.